Second Genome and Mayo Clinic Enter Collaboration to Develop Microbiome Therapeutics in Multiple Diseases

October 7, 2014, South San Francisco, CA

Read More

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Scientific Officer

September 2, 2014, South San Francisco, CA

Read More

Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in Obesity

May 2, 2014, South San Francisco, CA

Read More